Joseph W Kim

GU medical oncologist and Clinical Trialist. Specialize in #Genitourinary Cancers #Immunotherapy and #Targeted Therapies. All tweets and comments are my own.

[AACR @AACR]

.@AACR_CEO Margaret Foti announces the launch of the AACR Trailblazer Cancer Research Grants—which will provide nine $1 million grants to early-stage investigators and six $1 million grants to mid-career investigators—at the #AACR25 Opening Ceremony.

[FDA Oncology @FDAOncology]

Today, FDA Oncology Center Director Richard Pazdur, MD, accepted the @AACR 2025 Enduring Impact Award for Transformative Service to Cancer Science and Medicine from his former mentee, AACR President Dr. Patricia LoRusso, during the #AACR25 Annual Meeting Opening Ceremony.

[Ravi A Madan M.D. @Dr_RaviMadan]

As someone who worked with and (more importantly) learned from Mary @nciccr_gmb @NCIResearchCtr I am so happy to see that she is still inspiring excellence in oncology patient care. 🙏🏽

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

In well selected patients - solitary tumors < 7 cm, no or unilateral hydronephrosis, minimal CIS - results with TMT are comparable to Radical Cystectomy

#patientchoice #bladdercancer #BladderCancerMonth23

https://t.co/vxeUhoABFZ

@TheLancetOncol @BladderCancerUS

[AACR @AACR]

AACR members have elected Patricia M. LoRusso, DO, PhD (hc), as their 2023-2024 President-Elect. Dr. LoRusso will become President-Elect on April 17 during the #AACR23 Business Meeting of Members and will assume the Presidency during #AACR24. @YaleCancer @SmilowCancer

[Joseph W Kim @Joseph_W_Kim]

@BraunMDPhD @YaleCancer @YaleMed Congratulations, David!

[Joseph W Kim @Joseph_W_Kim]

@DrEricWiner @AACR @YaleCancer @SmilowCancer Pat always brings new energy, insights from her years of experience, and new creative ideas to transform how we do our clinical trials that are patient-centered and how we materialize and execute “ideas” into Research and Practice.

[Ravi A Madan M.D. @Dr_RaviMadan]

You are never too early or late in your training to say thank you and have mutual respect.

Care for Oncology patients is a team sport and our patients need and deserve the best teams we’ve got.

Thanks @ClayReedMD @theNCI

[Prostate Cancer Foundation @PCFnews]

We're excited to welcome William K. Oh, MD, an internationally recognized genitourinary (GU) oncologist with expertise in the use of systemic treatments for prostate cancer, has been appointed Chief Medical Officer (CMO).

https://t.co/f0wAZTwQzj

[Joseph W Kim @Joseph_W_Kim]

@PamelaKunzMD Congratulations!! @Cecchini_OncMD

[Joseph W Kim @Joseph_W_Kim]

@montypal @SWOG @theNCI @DanielPetrylak @ndenduluri1 @neerajaiims @DrVaishampayan @maughanonc @Parminder1699 @TiansterZhang @brian_rini @UroDocAsh @Uromigos @UroCancer @JoshMeeks @SWOGChair @SupportingSWOG It is certainly strange to attend SWOG mtg not hearing his voice with insightful comments. But the echos of his wisdom and legacy are resounding by many of his mentees #NickvogelzangRIP

[Sumanta K. Pal, MD, FASCO @montypal]

Hope to see many of you this AM at this @SWOG symposium dedicated to our dear friend/mentor/colleague #NickVogelzang. It was @theNCI cooperative group mtgs that brought us together; through them his legacy will live on. @DanielPetrylak @ndenduluri1 @neerajaiims @DrVaishampayan

[Joseph W Kim @Joseph_W_Kim]

@DrRanaMcKay @VanAllenLab @SwisherLiz @PrimoLaraMD @DrVaishampayan @LenAppleman @SerhanUnlu2 @DanielPetrylak

[Joseph W Kim @Joseph_W_Kim]

1/2 Thanks to all my amazing collaborators #ETCTN and @NCICTEP_ClinRes and @YaleCancer.
https://t.co/3ciZ177u1M

[Joseph W Kim @Joseph_W_Kim]

2/2, our study showed olaparib + cediranib improved median rPFS by 4.5 months with over olaparib alone with an HR=0.62. But it was associated with increased toxicity. Consistent with other reports, BRCA2 seems to be the most reliable biomarker of benefit. Check out our manuscript

[Christopher Sweeney, MBBS @ChrisSweens1]

Questions from #uromigoslive indicated some equate PSMA PET positive lesions withOUT conventional scan correlates with lesions seen on TcBone Scan and CT scan. These 2 slides propose they provide different biological information @Uromigos @neerajaiims @morr316 @Prof_Nick_James

[Joseph W Kim @Joseph_W_Kim]

We had a blast!

[Yale Cancer Center @YaleCancer]

Our medical oncology team gathered early at the Yale Bowl to kick off this morning’s @CTFRide in support of @SmilowCancer and @YaleCancer! @DrRoyHerbstYale @YaleMed @YaleHemOnc

[Yale Cancer Center @YaleCancer]

Our medical oncology team gathered early at the Yale Bowl to kick off this morning’s @CTFRide in support of @SmilowCancer and @YaleCancer! @DrRoyHerbstYale @YaleMed @YaleHemOnc

[Kidney Cancer @KidneyCancer]

⭐️Congratulations to KCA Trailblazer Award winner
@NazliDizman @YaleCancer @YaleMed! She will study the impact of CBM588 on metabolomic profile in patients with mRCC. #RCC #kidneycancer https://t.co/UHovzOkAmX

[Smilow Cancer Hospital @SmilowCancer]

Now being able to offer patients single-port robotic surgery for prostatectomies, Dr. Isaac Kim, says, “We’ve basically made prostatectomies an outpatient procedure.” Read more: https://t.co/rk1NWm8tik @YaleCancer @YaleMed @YNHH @Yale_Urology #prostatecancerawarenessmonth